Effect of hyperlipidemia on prognosis of the patients with hepatitis B related hepatocellular carcinoma
Journal Title: Journal of Surgery : Concepts & Practice - Year 2024, Vol 29, Issue 2
Abstract
[Objective] To explore the effect of hyperlipidemia and lipid-lowering therapy on the prognosis of postoperative patients with hepatitis B related hepatocellular carcinoma. [Methods] The clinical data of the patients with hepatitis B related hepatocellular carcinoma who were operated in our hospital from January 2012 to January 2021 were retrospectively collected. The effect of blood lipid level and related lipid-lowering therapy on the prognosis of postoperative patients with hepatitis B related hepatocellular carcinoma was analyzed. [Results] Among 166 patients with hepatitis B related hepatocellular carcinoma, there were 63 cases had hyperlipidemia, of which 33 cases were treated by statins. The median postoperative disease free survival time in the hyperlipidemia group was significantly lower than that in the normal blood lipid group (24.8 months vs. 38.5 months, P<0.05), and the median overall survival time in the hyperlipidemia group was also significantly lower than that in the normal blood lipid group (30.1 months vs. 44.5 months, P<0.05). There was no statistically significant difference in prognosis between the patients with hyperlipidemia who used statins or not. The median disease free survival time was 23.4 months vs. 26.3 months, and the median overall survival time was 29.7 months vs. 30.3 months. [Conclusions] Hyperlipidemia is a risk factor for disease free survival and overall survival after surgery in the patients with hepatitis B related hepatocellular carcinoma. The use of statins alone in hyperlipidemia patients cannot reduce the risk of recurrence and prolong survival time.
Authors and Affiliations
Qingjie SONG, Juanjuan TANG, Jianquan ZHAO, hui SONG, Jun YANG
Keywords
Related Articles
- EP ID EP750954
- DOI 10.16139/j.1007-9610.2024.02.09
- Views 17
- Downloads 0
Clinical significance of combination of anti-angiogenesis, immune checkpoint inhibitors and chemotherapy in the neoadjuvant treatment of locally advanced gastric cancer
The combination of anti-angiogenesis, immune checkpoint inhibitors(ICIs) and chemotherapy(target-immune-chemo) has achieved initial results in the comprehensive treatment of gastric cancer. Experimental studies have show...
Stage on development of pathophysiology of gallbladder stone and personalized diagnosis and treatment
Gallbladder stone (GS) is a common disease. There are no obvious symptoms at early stage for the patient with GS. Obstruction will cause acute cholecystitis. Secondary obstructive cholangitis of GS, biliary pancreatitis,...
Solitary cervical submental metastasis of papillary thyroid carcinoma: one case report
Solitary cervical submental nodule is a relatively rare case in clinical procedure and prone to miss diagnosis. Differential diagnosis with various head and neck diseases is necessary. This article reported a case of sol...
Classification and surgical treatment of congential biliary dilatation
Congential biliary dilitation (CBD) is rare biliary tract disease in clinic. Clinical classification and disease characteristics of CBD is the key of accurate treatment. Surgical treatment was regarded as the first choic...
Research on the management of the Glissonean pedicle in laparoscopic anatomical hemihepatectomy and the influence of indocyanine green dose on the fluorescence staining effect
[Objective] To investigate the technique and dosage selection of indocyanine green(ICG) fluorescence staining in laparoscopic anatomical hemihepatectomy. [Methods] A retrospective cross-sectional study was conducted. The...